Editorial: Molecular Mechanisms and New Therapeutic Targets in Epithelial to Mesenchymal Transition (EMT) and Fibrosis

被引：2
|
作者：
Battistelli, Cecilia [1 ]
Diederich, Marc [2 ]
Keane, Timothy Joseph [3 ]
Sandoval, Pilar [4 ]
Valente, Sergio [5 ]
Strippoli, Raffaele [1 ,6 ]
机构：
[1] Sapienza Univ Rome, Dept Mol Med, Rome, Italy
[2] Seoul Natl Univ, Dept Pharm, Seoul, South Korea
[3] Imperial Coll London, Dept Mat, London, England
[4] UAM, CSIC, Severo Ochoa Mol Biol Ctr, Madrid, Spain
[5] Sapienza Univ Rome, Dept Chem & Technol Drugs, Rome, Italy
[6] Natl Inst Infect Dis L Spallanzani IRCCS, Rome, Italy
来源：
FRONTIERS IN PHARMACOLOGY | 2020年 / 10卷
关键词：
natural compound; EMT; fibrosis; epigenetics; non-coding RNAs; therapeutic targets;
D O I：
10.3389/fphar.2019.01556
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Galectins in epithelial-mesenchymal transition: roles and mechanisms contributing to tissue repair, fibrosis and cancer metastasis
    Perez-Moreno, Elisa
    Oyanadel, Claudia
    de la Pena, Adely
    Hernandez, Ronny
    Perez-Molina, Francisca
    Metz, Claudia
    Gonzalez, Alfonso
    Soza, Andrea
    BIOLOGICAL RESEARCH, 2024, 57 (01)
  • [22] Molecular profiling supports the role of epithelial-to-mesenchymal transition (EMT) in ovarian cancer metastasis
    Lili, Loukia N.
    Matyunina, Lilya V.
    Walker, L. DeEtte
    Wells, Stephen L.
    Benigno, Benedict B.
    McDonald, John F.
    JOURNAL OF OVARIAN RESEARCH, 2013, 6
  • [23] The rejuvenated scenario of epithelial–mesenchymal transition (EMT) and cancer metastasis
    Fanyan Meng
    Guojun Wu
    Cancer and Metastasis Reviews, 2012, 31 : 455 - 467
  • [24] Molecular Pathogenesis of Chlamydia Disease Complications: Epithelial-Mesenchymal Transition and Fibrosis
    Igietseme, Joseph U.
    Omosun, Yusuf
    Nagy, Tamas
    Stuchlik, Olga
    Reed, Matthew S.
    He, Qing
    Partin, James
    Joseph, Kahaliah
    Ellerson, Debra
    George, Zenas
    Goldstein, Jason
    Eko, Francis O.
    Bandea, Claudiu
    Pohl, Jan
    Black, Carolyn M.
    INFECTION AND IMMUNITY, 2018, 86 (01)
  • [25] The involvement of epithelial-to-mesenchymal transition in doxorubicin resistance: Possible molecular targets
    Mirzaei, Sepideh
    Abadi, Asal Jalal
    Gholami, Mohammad Hossein
    Hashemi, Farid
    Zabolian, Amirhossein
    Hushmandi, Kiavash
    Zarrabi, Ali
    Entezari, Maliheh
    Aref, Amir Reza
    Khan, Haroon
    Ashrafizadeh, Milad
    Samarghandian, Saeed
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 908
  • [26] Epithelial-to-Mesenchymal Transition in Fibrosis: Concepts and Targeting Strategies
    Lovisa, Sara
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [27] Role of Metabolic Reprogramming in Epithelial-Mesenchymal Transition (EMT)
    Kang, Hyunkoo
    Kim, Hyunwoo
    Lee, Sungmin
    Youn, HyeSook
    Youn, BuHyun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (08)
  • [28] Unraveling the function of epithelial-mesenchymal transition (EMT) in colorectal cancer: Metastasis, therapy response, and revisiting molecular pathways
    Sabouni, Eisa
    Nejad, Melina Maghsodlou
    Mojtabavi, Sarah
    Khoshdooz, Sara
    Mojtabavi, Mahsa
    Nadafzadeh, Niloufar
    Nikpanjeh, Negin
    Mirzaei, Sepideh
    Hashemi, Mehrdad
    Aref, Amir Reza
    Khorrami, Ramin
    Nabavi, Noushin
    Ertas, Yavuz Nuri
    Salimimoghadam, Shokooh
    Zandieh, Mohammad Arad
    Rahmanian, Parham
    Taheriazam, Afshin
    Hushmandi, Kiavash
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 160
  • [29] Involvement of Epithelial-Mesenchymal Transition (EMT) in Autoimmune Diseases
    Sarrand, Julie
    Soyfoo, Muhammad S.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (19)
  • [30] Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT) From cancer stem cells to aging-associated fibrosis
    Cufi, Silvia
    Vazquez-Martin, Alejandro
    Oliveras-Ferraros, Cristina
    Martin-Castillo, Begona
    Joven, Jorge
    Menendez, Javier A.
    CELL CYCLE, 2010, 9 (22) : 4461 - 4468
12345